Trding as always you are great,....Thank you ..

Well , I do have a questions here , first I really don't understand what is a reason that we reporting 0-10 weeks results , and then second results >10 weeks ...

I spoke with some friends who used to work in pharma and they said sometimes it is done this way...I still don't understand why , but it is done .....

Then , my understanding was that those new results are with longer overlap time ..
You don't think so ....

Well , since almost from the beginning of this year we know that with longer overlap results are so much better ,
( since we know much more accurate half life of Leronlimab now... )
why we will not present those results ? ...
Or what % of those patients are with longer overlap......

Those are mine questions ,
I did ask in e-mail few days ago but didn't get an answer ...
I am very intrigue with them so still trying to get answers somehow ...

And of course we know that our patients were matched with dose of Leronlimab randomly chosen until now ,

so in our pivotal mono where we be using Receptor Occupancy Test , results should be even much better ...

Yes , all very challenging and exciting to me...



And all IMO.